Cargando…

Approaches to manage ‘affordability’ of high budget impact medicines in key EU countries

Background: The launch of hepatitis C (HCV) drugs such as sofosbuvir or ledipasvir has fostered the question of affordability of novel high budget impact therapies even in countries with high domestic product. European countries have developed a variety of mechanisms to improve affordability of such...

Descripción completa

Detalles Bibliográficos
Autores principales:	Flume, Mathias, Bardou, Marc, Capri, Stefano, Sola-Morales, Oriol, Cunningham, David, Levin, Lars-Ake, Postma, Maarten J., Touchot, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Routledge 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998770/ https://www.ncbi.nlm.nih.gov/pubmed/29915664 http://dx.doi.org/10.1080/20016689.2018.1478539

Ejemplares similares

Feasibility and attractiveness of indication value-based pricing in key EU countries
por: Flume, Mathias, et al.
Publicado: (2016)

Early Insights from Commercialization of Gene Therapies in Europe
por: Touchot, Nicolas, et al.
Publicado: (2017)

Ethical Hurdles in the Prioritization of Oncology Care
por: de Groot, Folkert, et al.
Publicado: (2016)

Affordability of oncology drugs: accuracy of budget impact estimations
por: Geenen, Joost W., et al.
Publicado: (2019)

Return-to-work intervention for cancer survivors: budget impact and allocation of costs and returns in the Netherlands and six major EU-countries
por: Mewes, Janne C., et al.
Publicado: (2015)

Das EU-Budget in der Corona-Krise
por: Henke, Klaus-Dirk
Publicado: (2020)

Budget constraint and vaccine dosing: a mathematical modelling exercise
por: Standaert, Baudouin A, et al.
Publicado: (2014)

Short-term budget affordability of hepatitis C treatments for state Medicaid programs
por: Chou, Jacquelyn W., et al.
Publicado: (2019)

Value Insider Season 1 Episode 3: How Does Budget Impact and Affordability in Healthcare Work? (BI and Affordability) [Podcast]
por: Sullivan, Sean D, et al.
Publicado: (2022)

Global Budgeting in the OECD Countries
por: Wolfe, Patrice R., et al.
Publicado: (1993)

Use of budget savings from patent expiration of cancer drugs to improve affordability and accessibility
por: Lee, Seung Mi, et al.
Publicado: (2021)

EU-Wide Access to High-quality, Affordable Precision Diagnostics: An EHA Position Paper
por: Macintyre, Elizabeth, et al.
Publicado: (2020)

Budget and health impact of switching eligible patients with atrial fibrillation to lower- dose dabigatran
por: Fens, Tanja, et al.
Publicado: (2023)

Budget Impact Analysis of the Introduction of Rituximab and Trastuzumab Intravenous Biosimilars to EU-5 Markets
por: Jang, Minyoung, et al.
Publicado: (2020)

Budget Impact Analysis of Metformin Sustained Release for the Treatment of Type 2 Diabetes in The Netherlands
por: Gout-Zwart, Judith J., et al.
Publicado: (2019)

Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium–olodaterol for patients with COPD in the Netherlands
por: van Boven, Job FM, et al.
Publicado: (2016)

Assessment of the Development of Poverty in EU Countries
por: Sompolska-Rzechuła, Agnieszka, et al.
Publicado: (2022)

The role of stakeholder involvement in the evolving EU HTA process: Insights generated through the European Access Academy’s multi-stakeholder pre-convention questionnaire
por: Van Haesendonck, Lauren, et al.
Publicado: (2023)

Budget impact analysis for avatrombopag in the treatment of chronic primary immune thrombocytopenia in adult patients refractory to other treatments
por: Aiello, Andrea, et al.
Publicado: (2023)

Estimated Budget Impact of Adopting the Affordable Care Act’s Required Smoking Cessation Coverage on United States Healthcare Payers
por: Baker, Christine L., et al.
Publicado: (2016)

Budget line items for immunization in 33 African countries
por: Griffiths, Ulla K, et al.
Publicado: (2020)

Ocean submesoscales as a key component of the global heat budget
por: Su, Zhan, et al.
Publicado: (2018)

Budget Impact Analysis of a Renal Point-of-Care Test in Dutch Community Pharmacies to Prevent Antibiotic-Related Hospitalizations
por: Gout-Zwart, Judith J., et al.
Publicado: (2018)

Key Factors Influencing Use of Immunization Cost Evidence in Country Planning and Budgeting Processes: Experiences From Indonesia, Tanzania, and Vietnam
por: Ozaltin, Annette, et al.
Publicado: (2022)

Cervical cancer prevention in Indonesia: An updated clinical impact, cost-effectiveness and budget impact analysis
por: Setiawan, Didik, et al.
Publicado: (2020)

Cost-effectiveness analysis and budget impact of rivaroxaban compared with dalteparin in patients with cancer at risk of recurrent venous thromboembolism
por: de Jong, Lisa A, et al.
Publicado: (2020)

Vehicle being transferred to an EU country - (with SIV No.)
Publicado: (2016)

Can only poorer European countries afford large carnivores?
por: Kojola, Ilpo, et al.
Publicado: (2018)

Affordable clean energy transition in developing countries: Pathways and technologies
por: Babayomi, Oluleke O., et al.
Publicado: (2022)

Affordability of essential medicines: The case of fluoride toothpaste in 78 countries
por: Gkekas, Athanasios, et al.
Publicado: (2022)

Availability, use, and affordability of medicines in urban China under universal health coverage: an empirical study in Hangzhou and Baoji
por: Huang, Yunyu, et al.
Publicado: (2018)

Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research
por: van Asselt, Thea, et al.
Publicado: (2017)

Peroxynitrite Is a Key Mediator of the Cardioprotection Afforded by Ischemic Postconditioning In Vivo
por: Li, Jianhui, et al.
Publicado: (2013)

The Evolution of Affordable Technologies in Liquid Biopsy Diagnostics: The Key to Clinical Implementation
por: Alexandrou, George, et al.
Publicado: (2023)

Economic impact of new active substance status on EU payers’ budgets: example of dimethyl fumarate (Tecfidera(®)) for multiple sclerosis
por: Toumi, Mondher, et al.
Publicado: (2014)

Age- and risk-related appropriateness of the use of available influenza vaccines in the Italian elderly population is advantageous: results from a budget impact analysis
por: BARBIERI, M., et al.
Publicado: (2017)

Vehicle being transferred to an EU country - (without SIV No.)
Publicado: (2016)

Countries split from EU on COVID-19 vaccines
por: Holt, Ed
Publicado: (2021)

Achieving affordable critical care in low-income and middle-income countries
por: Turner, Hugo C, et al.
Publicado: (2019)

Improving access to affordable vaccines for middle-income countries in the african region
por: Mihigo, Richard, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_iei3cgrmu1ntbaojj54hmfj9dh